A lawsuit was filed on behalf of investors in Instacart (Maplebear Inc.) (NASDAQ: CART) shares over alleged securities laws violations.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in Endeavour Mining plc (OTC: EDVMF) shares over potential securities laws violations by Endeavour Mining plc was announced.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

A lawsuit was filed on behalf of investors in Evolution AB (publ) (OTC: EVVTY) shares over alleged securities laws violations.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in Equity LifeStyle Properties, Inc. (NYSE: ELS) shares over potential securities laws violations by Equity LifeStyle Properties, Inc. was announced.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in Theratechnologies Inc. (NASDAQ: THTX) shares over potential securities laws violations by Theratechnologies Inc. was announced.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in PTC Therapeutics, Inc. (NASDAQ: PTCT) shares over potential securities laws violations by PTC Therapeutics, Inc. was announced.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."

Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.

Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

A lawsuit was filed on behalf of investors in Archer-Daniels-Midland Company (NYSE: ADM) shares over alleged securities laws violations.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."

Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.

Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by PTC Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

South Plainfield, NJ based PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. PTC Therapeutics, Inc. reported that its annual Total Revenue rose from $538.59 million in 2021 to $698.8 million in 2022, and that its Net Loss increased from $523.9 million in 2021 to $551.89 million in 2022.

On September 15, 2023, PTC Therapeutics, Inc. issued a press release "announc[ing] . . . that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). The negative opinion also applies to the renewal of the existing conditional authorization."

Then on January 25, 2024, CHMP for a second time issued a negative opinion on Translarna. The negative opinion issued by the Committee will result in the withdrawal of the therapy in Europe.

Those who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Christopher Clausen

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in United States Steel Corporation (NYSE: X) shares over potential securities laws violations by United States Steel Corporation was announced.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."

Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.

Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by PTC Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

South Plainfield, NJ based PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. PTC Therapeutics, Inc. reported that its annual Total Revenue rose from $538.59 million in 2021 to $698.8 million in 2022, and that its Net Loss increased from $523.9 million in 2021 to $551.89 million in 2022.

On September 15, 2023, PTC Therapeutics, Inc. issued a press release "announc[ing] . . . that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). The negative opinion also applies to the renewal of the existing conditional authorization."

Then on January 25, 2024, CHMP for a second time issued a negative opinion on Translarna. The negative opinion issued by the Committee will result in the withdrawal of the therapy in Europe.

Those who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Christopher Clausen

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NYSE: ADM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Chicago, IL based Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. On January 22, 2024, Archer-Daniels-Midland Company placed CFO Vikram Luthar on administrative leave in response to an investigation into accounting practices in its nutrition segment. Archer-Daniels-Midland Company said it will delay publishing its Q4 and FY 2023 results and has withdrawn all forward guidance on the nutrition segment.

Shares of Archer-Daniels-Midland Company (NYSE: ADM) declined from over $87 per share on August 2023 to as low as $50.72 per share on January 25, 2024.

The plaintiff claims that between April 30, 2020 and January 22, 2024, the Defendants made false and/or misleading statements, as well as failed to disclose material facts, about the performance and prospects of Archer-Daniels-Midland Company's Nutrition segment and its accounting practices, and that the Defendants made positive statements about the Nutrition segment as a future profit-driver for the Company, with the ability to capitalize on healthier eating trends and rising consumer demand for natural ingredients and flavoring. Defendants also created the impression that the Nutrition segment's growth would provide more diversification and earnings stability for Archer-Daniels-Midland Company.

The plaintiff claims that unbeknownst to investors, however, the Nutrition segment's ostensibly impressive growth was inaccurate and subject to improper accounting practices, and Defendants also downplayed the segment's eventual decline in 2023, that as Archer-Daniels-Midland Company was aggressively acquiring companies to expand its capabilities in Nutrition, investors were under the impression that the segment was growing rapidly, that as alleged, Defendants' accounting practices for the segment misrepresented its true financial results and prospects, including its operating profits ("OP"), that between April 30, 2020 and January 22, 2024, the defendants were incentivized to create the appearance of a diversified business by inflating the performance of the Nutrition segment, and the Individual Defendants were further incentivized by stock awards that were directly tied to the performance of the Nutrition segment from 2020 to 2022, and that as a result, Archer-Daniels-Midland Company's business and prospects were much worse than represented by Defendants, causing the price of Archer-Daniels-Midland Company common stock to trade at artificially inflated levels between April 30, 2020 and January 22, 2024.

Those who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in Allakos Inc. (NASDAQ: ALLK) shares over potential securities laws violations by Allakos Inc. was announced.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."

Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.

Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by PTC Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

South Plainfield, NJ based PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. PTC Therapeutics, Inc. reported that its annual Total Revenue rose from $538.59 million in 2021 to $698.8 million in 2022, and that its Net Loss increased from $523.9 million in 2021 to $551.89 million in 2022.

On September 15, 2023, PTC Therapeutics, Inc. issued a press release "announc[ing] . . . that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). The negative opinion also applies to the renewal of the existing conditional authorization."

Then on January 25, 2024, CHMP for a second time issued a negative opinion on Translarna. The negative opinion issued by the Committee will result in the withdrawal of the therapy in Europe.

Those who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Christopher Clausen

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NYSE: ADM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Chicago, IL based Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. On January 22, 2024, Archer-Daniels-Midland Company placed CFO Vikram Luthar on administrative leave in response to an investigation into accounting practices in its nutrition segment. Archer-Daniels-Midland Company said it will delay publishing its Q4 and FY 2023 results and has withdrawn all forward guidance on the nutrition segment.

Shares of Archer-Daniels-Midland Company (NYSE: ADM) declined from over $87 per share on August 2023 to as low as $50.72 per share on January 25, 2024.

The plaintiff claims that between April 30, 2020 and January 22, 2024, the Defendants made false and/or misleading statements, as well as failed to disclose material facts, about the performance and prospects of Archer-Daniels-Midland Company's Nutrition segment and its accounting practices, and that the Defendants made positive statements about the Nutrition segment as a future profit-driver for the Company, with the ability to capitalize on healthier eating trends and rising consumer demand for natural ingredients and flavoring. Defendants also created the impression that the Nutrition segment's growth would provide more diversification and earnings stability for Archer-Daniels-Midland Company.

The plaintiff claims that unbeknownst to investors, however, the Nutrition segment's ostensibly impressive growth was inaccurate and subject to improper accounting practices, and Defendants also downplayed the segment's eventual decline in 2023, that as Archer-Daniels-Midland Company was aggressively acquiring companies to expand its capabilities in Nutrition, investors were under the impression that the segment was growing rapidly, that as alleged, Defendants' accounting practices for the segment misrepresented its true financial results and prospects, including its operating profits ("OP"), that between April 30, 2020 and January 22, 2024, the defendants were incentivized to create the appearance of a diversified business by inflating the performance of the Nutrition segment, and the Individual Defendants were further incentivized by stock awards that were directly tied to the performance of the Nutrition segment from 2020 to 2022, and that as a result, Archer-Daniels-Midland Company's business and prospects were much worse than represented by Defendants, causing the price of Archer-Daniels-Midland Company common stock to trade at artificially inflated levels between April 30, 2020 and January 22, 2024.

Those who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of United States Steel Corporation (NYSE: X), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by United States Steel Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Pittsburgh, PA based United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe.

United States Steel Corporation reported that its annual Total Revenue rose from over $20.27 billion in 2021 to over $21.06 billion in 2022, and that its Net Income declined from over $4.17 billion in 2021 to over $2.52 billion in 2022.

Shares of United States Steel Corporation (NYSE: X) closed on February 07, 2024, at $46.07 per share.

Those who purchased shares of United States Steel Corporation (NYSE: X) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in Milestone Pharmaceuticals Inc. (NASDAQ: MIST) shares over potential securities laws violations by Milestone Pharmaceuticals Inc. was announced.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."

Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.

Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by PTC Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

South Plainfield, NJ based PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. PTC Therapeutics, Inc. reported that its annual Total Revenue rose from $538.59 million in 2021 to $698.8 million in 2022, and that its Net Loss increased from $523.9 million in 2021 to $551.89 million in 2022.

On September 15, 2023, PTC Therapeutics, Inc. issued a press release "announc[ing] . . . that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). The negative opinion also applies to the renewal of the existing conditional authorization."

Then on January 25, 2024, CHMP for a second time issued a negative opinion on Translarna. The negative opinion issued by the Committee will result in the withdrawal of the therapy in Europe.

Those who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Christopher Clausen

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NYSE: ADM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Chicago, IL based Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. On January 22, 2024, Archer-Daniels-Midland Company placed CFO Vikram Luthar on administrative leave in response to an investigation into accounting practices in its nutrition segment. Archer-Daniels-Midland Company said it will delay publishing its Q4 and FY 2023 results and has withdrawn all forward guidance on the nutrition segment.

Shares of Archer-Daniels-Midland Company (NYSE: ADM) declined from over $87 per share on August 2023 to as low as $50.72 per share on January 25, 2024.

The plaintiff claims that between April 30, 2020 and January 22, 2024, the Defendants made false and/or misleading statements, as well as failed to disclose material facts, about the performance and prospects of Archer-Daniels-Midland Company's Nutrition segment and its accounting practices, and that the Defendants made positive statements about the Nutrition segment as a future profit-driver for the Company, with the ability to capitalize on healthier eating trends and rising consumer demand for natural ingredients and flavoring. Defendants also created the impression that the Nutrition segment's growth would provide more diversification and earnings stability for Archer-Daniels-Midland Company.

The plaintiff claims that unbeknownst to investors, however, the Nutrition segment's ostensibly impressive growth was inaccurate and subject to improper accounting practices, and Defendants also downplayed the segment's eventual decline in 2023, that as Archer-Daniels-Midland Company was aggressively acquiring companies to expand its capabilities in Nutrition, investors were under the impression that the segment was growing rapidly, that as alleged, Defendants' accounting practices for the segment misrepresented its true financial results and prospects, including its operating profits ("OP"), that between April 30, 2020 and January 22, 2024, the defendants were incentivized to create the appearance of a diversified business by inflating the performance of the Nutrition segment, and the Individual Defendants were further incentivized by stock awards that were directly tied to the performance of the Nutrition segment from 2020 to 2022, and that as a result, Archer-Daniels-Midland Company's business and prospects were much worse than represented by Defendants, causing the price of Archer-Daniels-Midland Company common stock to trade at artificially inflated levels between April 30, 2020 and January 22, 2024.

Those who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of United States Steel Corporation (NYSE: X), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by United States Steel Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Pittsburgh, PA based United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe.

United States Steel Corporation reported that its annual Total Revenue rose from over $20.27 billion in 2021 to over $21.06 billion in 2022, and that its Net Income declined from over $4.17 billion in 2021 to over $2.52 billion in 2022.

Shares of United States Steel Corporation (NYSE: X) closed on February 07, 2024, at $46.07 per share.

Those who purchased shares of United States Steel Corporation (NYSE: X) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Allakos Inc. (NASDAQ: ALLK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) concerning whether certain statements by Allakos Inc. (regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Carlos, CA based Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. On January 16, 2023, Allakos Inc. issued a press release "announc[ing] a restructuring to reduce costs and to focus on AK006 clinical development and additional preclinical programs." The Company stated that it "will halt lirentelimab-related activities across clinical, manufacturing, research and administrative functions" and, "[a]s a result, the Company will reduce its workforce by approximately 50%."

Shares of Allakos Inc. (NASDAQ: ALLK) declined from $3.41 per share on December 18, 2023, to as low as $1.00 per share on January 17, 2024.

Those who purchased shares of Allakos Inc. (NASDAQ: ALLK) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

A lawsuit was filed on behalf of investors in B. Riley Financial, Inc. (NASDAQ: RILY) shares over alleged securities laws violations.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."

Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.

Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by PTC Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

South Plainfield, NJ based PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. PTC Therapeutics, Inc. reported that its annual Total Revenue rose from $538.59 million in 2021 to $698.8 million in 2022, and that its Net Loss increased from $523.9 million in 2021 to $551.89 million in 2022.

On September 15, 2023, PTC Therapeutics, Inc. issued a press release "announc[ing] . . . that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). The negative opinion also applies to the renewal of the existing conditional authorization."

Then on January 25, 2024, CHMP for a second time issued a negative opinion on Translarna. The negative opinion issued by the Committee will result in the withdrawal of the therapy in Europe.

Those who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Christopher Clausen

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NYSE: ADM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Chicago, IL based Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. On January 22, 2024, Archer-Daniels-Midland Company placed CFO Vikram Luthar on administrative leave in response to an investigation into accounting practices in its nutrition segment. Archer-Daniels-Midland Company said it will delay publishing its Q4 and FY 2023 results and has withdrawn all forward guidance on the nutrition segment.

Shares of Archer-Daniels-Midland Company (NYSE: ADM) declined from over $87 per share on August 2023 to as low as $50.72 per share on January 25, 2024.

The plaintiff claims that between April 30, 2020 and January 22, 2024, the Defendants made false and/or misleading statements, as well as failed to disclose material facts, about the performance and prospects of Archer-Daniels-Midland Company's Nutrition segment and its accounting practices, and that the Defendants made positive statements about the Nutrition segment as a future profit-driver for the Company, with the ability to capitalize on healthier eating trends and rising consumer demand for natural ingredients and flavoring. Defendants also created the impression that the Nutrition segment's growth would provide more diversification and earnings stability for Archer-Daniels-Midland Company.

The plaintiff claims that unbeknownst to investors, however, the Nutrition segment's ostensibly impressive growth was inaccurate and subject to improper accounting practices, and Defendants also downplayed the segment's eventual decline in 2023, that as Archer-Daniels-Midland Company was aggressively acquiring companies to expand its capabilities in Nutrition, investors were under the impression that the segment was growing rapidly, that as alleged, Defendants' accounting practices for the segment misrepresented its true financial results and prospects, including its operating profits ("OP"), that between April 30, 2020 and January 22, 2024, the defendants were incentivized to create the appearance of a diversified business by inflating the performance of the Nutrition segment, and the Individual Defendants were further incentivized by stock awards that were directly tied to the performance of the Nutrition segment from 2020 to 2022, and that as a result, Archer-Daniels-Midland Company's business and prospects were much worse than represented by Defendants, causing the price of Archer-Daniels-Midland Company common stock to trade at artificially inflated levels between April 30, 2020 and January 22, 2024.

Those who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of United States Steel Corporation (NYSE: X), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by United States Steel Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Pittsburgh, PA based United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe.

United States Steel Corporation reported that its annual Total Revenue rose from over $20.27 billion in 2021 to over $21.06 billion in 2022, and that its Net Income declined from over $4.17 billion in 2021 to over $2.52 billion in 2022.

Shares of United States Steel Corporation (NYSE: X) closed on February 07, 2024, at $46.07 per share.

Those who purchased shares of United States Steel Corporation (NYSE: X) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Allakos Inc. (NASDAQ: ALLK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) concerning whether certain statements by Allakos Inc. (regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Carlos, CA based Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. On January 16, 2023, Allakos Inc. issued a press release "announc[ing] a restructuring to reduce costs and to focus on AK006 clinical development and additional preclinical programs." The Company stated that it "will halt lirentelimab-related activities across clinical, manufacturing, research and administrative functions" and, "[a]s a result, the Company will reduce its workforce by approximately 50%."

Shares of Allakos Inc. (NASDAQ: ALLK) declined from $3.41 per share on December 18, 2023, to as low as $1.00 per share on January 17, 2024.

Those who purchased shares of Allakos Inc. (NASDAQ: ALLK) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Milestone Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Montreal, Canada based Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. On or about May 9, 2019, Milestone Pharmaceuticals Inc. sold about 5.5 million shares of stock in its initial public stock offering (the "IPO"), at $15.00 a share raising approximately $82,500,000 in new capital.

On December 26, 2023, Milestone Pharmaceuticals Inc announced that it had received a Refuse to File ("RFT") letter from the U.S. Food and Drug Administration ("FDA") for its recently submitted New Drug Application ("NDA") for its lead candidate, Etripamil, a self-administered nasal spray for the treatment of paroxysmal supraventricular tachycardia. The Company advised that, in the RFT, the FDA had "determined that the NDA, submitted in October 2023, was not sufficiently complete to permit substantive review" and "requested clarification about the time of data recorded for adverse events in Phase 3 clinical trials".

Shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) declined from $1.33 per share on January 22, 2024.

Those who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in Ramaco Resources, Inc. (NASDAQ: METC) shares over potential securities laws violations by Ramaco Resources, Inc. was announced.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."

Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.

Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by PTC Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

South Plainfield, NJ based PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. PTC Therapeutics, Inc. reported that its annual Total Revenue rose from $538.59 million in 2021 to $698.8 million in 2022, and that its Net Loss increased from $523.9 million in 2021 to $551.89 million in 2022.

On September 15, 2023, PTC Therapeutics, Inc. issued a press release "announc[ing] . . . that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). The negative opinion also applies to the renewal of the existing conditional authorization."

Then on January 25, 2024, CHMP for a second time issued a negative opinion on Translarna. The negative opinion issued by the Committee will result in the withdrawal of the therapy in Europe.

Those who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Christopher Clausen

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NYSE: ADM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Chicago, IL based Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. On January 22, 2024, Archer-Daniels-Midland Company placed CFO Vikram Luthar on administrative leave in response to an investigation into accounting practices in its nutrition segment. Archer-Daniels-Midland Company said it will delay publishing its Q4 and FY 2023 results and has withdrawn all forward guidance on the nutrition segment.

Shares of Archer-Daniels-Midland Company (NYSE: ADM) declined from over $87 per share on August 2023 to as low as $50.72 per share on January 25, 2024.

The plaintiff claims that between April 30, 2020 and January 22, 2024, the Defendants made false and/or misleading statements, as well as failed to disclose material facts, about the performance and prospects of Archer-Daniels-Midland Company's Nutrition segment and its accounting practices, and that the Defendants made positive statements about the Nutrition segment as a future profit-driver for the Company, with the ability to capitalize on healthier eating trends and rising consumer demand for natural ingredients and flavoring. Defendants also created the impression that the Nutrition segment's growth would provide more diversification and earnings stability for Archer-Daniels-Midland Company.

The plaintiff claims that unbeknownst to investors, however, the Nutrition segment's ostensibly impressive growth was inaccurate and subject to improper accounting practices, and Defendants also downplayed the segment's eventual decline in 2023, that as Archer-Daniels-Midland Company was aggressively acquiring companies to expand its capabilities in Nutrition, investors were under the impression that the segment was growing rapidly, that as alleged, Defendants' accounting practices for the segment misrepresented its true financial results and prospects, including its operating profits ("OP"), that between April 30, 2020 and January 22, 2024, the defendants were incentivized to create the appearance of a diversified business by inflating the performance of the Nutrition segment, and the Individual Defendants were further incentivized by stock awards that were directly tied to the performance of the Nutrition segment from 2020 to 2022, and that as a result, Archer-Daniels-Midland Company's business and prospects were much worse than represented by Defendants, causing the price of Archer-Daniels-Midland Company common stock to trade at artificially inflated levels between April 30, 2020 and January 22, 2024.

Those who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of United States Steel Corporation (NYSE: X), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by United States Steel Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Pittsburgh, PA based United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe.

United States Steel Corporation reported that its annual Total Revenue rose from over $20.27 billion in 2021 to over $21.06 billion in 2022, and that its Net Income declined from over $4.17 billion in 2021 to over $2.52 billion in 2022.

Shares of United States Steel Corporation (NYSE: X) closed on February 07, 2024, at $46.07 per share.

Those who purchased shares of United States Steel Corporation (NYSE: X) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Allakos Inc. (NASDAQ: ALLK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) concerning whether certain statements by Allakos Inc. (regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Carlos, CA based Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. On January 16, 2023, Allakos Inc. issued a press release "announc[ing] a restructuring to reduce costs and to focus on AK006 clinical development and additional preclinical programs." The Company stated that it "will halt lirentelimab-related activities across clinical, manufacturing, research and administrative functions" and, "[a]s a result, the Company will reduce its workforce by approximately 50%."

Shares of Allakos Inc. (NASDAQ: ALLK) declined from $3.41 per share on December 18, 2023, to as low as $1.00 per share on January 17, 2024.

Those who purchased shares of Allakos Inc. (NASDAQ: ALLK) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Milestone Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Montreal, Canada based Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. On or about May 9, 2019, Milestone Pharmaceuticals Inc. sold about 5.5 million shares of stock in its initial public stock offering (the "IPO"), at $15.00 a share raising approximately $82,500,000 in new capital.

On December 26, 2023, Milestone Pharmaceuticals Inc announced that it had received a Refuse to File ("RFT") letter from the U.S. Food and Drug Administration ("FDA") for its recently submitted New Drug Application ("NDA") for its lead candidate, Etripamil, a self-administered nasal spray for the treatment of paroxysmal supraventricular tachycardia. The Company advised that, in the RFT, the FDA had "determined that the NDA, submitted in October 2023, was not sufficiently complete to permit substantive review" and "requested clarification about the time of data recorded for adverse events in Phase 3 clinical trials".

Shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) declined from $1.33 per share on January 22, 2024.

Those who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of B. Riley Financial, Inc. (NASDAQ: RILY) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: RILY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Los Angeles, CA based B. Riley Financial, Inc., through its subsidiaries, provides financial services to corporate, institutional, and high net worth clients in North America, Australia, and Europe.

On January 21, 2024, Bloomberg News released an article entitled "SEC Probes B. Riley Deals With Client Tied to Failed Fund". This article stated in pertinent part that "U.S. authorities are investigating B. Riley Financial's deals with a client who was linked to a securities fraud, and the use of his assets to help the investment bank obtain a loan from Nomura Holdings Inc., according to people familiar with the matter."

Shares of B. Riley Financial, Inc. (NASDAQ: RILY) declined from $60.72 per share in July 2023, to as low as $18.09 per share on January 22, 2024.

The plaintiff claims that between May 10, 2023 and November 9, 2023, the Defendants failed to disclose to investors that Brian Kahn had been credibly implicated in a conspiracy to defraud investors of millions of dollars, that, in spite of this involvement, B. Riley continued to finance the transaction enabling Kahn and others to take FRG private through complex arrangements, that the foregoing was reasonably likely to draw regulatory scrutiny to B. Riley, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of B. Riley Financial, Inc. (NASDAQ: RILY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation on behalf of investors in Anywhere Real Estate Inc. (NYSE: HOUS) shares over potential wrongdoing at Anywhere Real Estate Inc. was announced.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."

Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.

Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by PTC Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

South Plainfield, NJ based PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. PTC Therapeutics, Inc. reported that its annual Total Revenue rose from $538.59 million in 2021 to $698.8 million in 2022, and that its Net Loss increased from $523.9 million in 2021 to $551.89 million in 2022.

On September 15, 2023, PTC Therapeutics, Inc. issued a press release "announc[ing] . . . that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). The negative opinion also applies to the renewal of the existing conditional authorization."

Then on January 25, 2024, CHMP for a second time issued a negative opinion on Translarna. The negative opinion issued by the Committee will result in the withdrawal of the therapy in Europe.

Those who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Christopher Clausen

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NYSE: ADM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Chicago, IL based Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. On January 22, 2024, Archer-Daniels-Midland Company placed CFO Vikram Luthar on administrative leave in response to an investigation into accounting practices in its nutrition segment. Archer-Daniels-Midland Company said it will delay publishing its Q4 and FY 2023 results and has withdrawn all forward guidance on the nutrition segment.

Shares of Archer-Daniels-Midland Company (NYSE: ADM) declined from over $87 per share on August 2023 to as low as $50.72 per share on January 25, 2024.

The plaintiff claims that between April 30, 2020 and January 22, 2024, the Defendants made false and/or misleading statements, as well as failed to disclose material facts, about the performance and prospects of Archer-Daniels-Midland Company's Nutrition segment and its accounting practices, and that the Defendants made positive statements about the Nutrition segment as a future profit-driver for the Company, with the ability to capitalize on healthier eating trends and rising consumer demand for natural ingredients and flavoring. Defendants also created the impression that the Nutrition segment's growth would provide more diversification and earnings stability for Archer-Daniels-Midland Company.

The plaintiff claims that unbeknownst to investors, however, the Nutrition segment's ostensibly impressive growth was inaccurate and subject to improper accounting practices, and Defendants also downplayed the segment's eventual decline in 2023, that as Archer-Daniels-Midland Company was aggressively acquiring companies to expand its capabilities in Nutrition, investors were under the impression that the segment was growing rapidly, that as alleged, Defendants' accounting practices for the segment misrepresented its true financial results and prospects, including its operating profits ("OP"), that between April 30, 2020 and January 22, 2024, the defendants were incentivized to create the appearance of a diversified business by inflating the performance of the Nutrition segment, and the Individual Defendants were further incentivized by stock awards that were directly tied to the performance of the Nutrition segment from 2020 to 2022, and that as a result, Archer-Daniels-Midland Company's business and prospects were much worse than represented by Defendants, causing the price of Archer-Daniels-Midland Company common stock to trade at artificially inflated levels between April 30, 2020 and January 22, 2024.

Those who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of United States Steel Corporation (NYSE: X), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by United States Steel Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Pittsburgh, PA based United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe.

United States Steel Corporation reported that its annual Total Revenue rose from over $20.27 billion in 2021 to over $21.06 billion in 2022, and that its Net Income declined from over $4.17 billion in 2021 to over $2.52 billion in 2022.

Shares of United States Steel Corporation (NYSE: X) closed on February 07, 2024, at $46.07 per share.

Those who purchased shares of United States Steel Corporation (NYSE: X) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Allakos Inc. (NASDAQ: ALLK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) concerning whether certain statements by Allakos Inc. (regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Carlos, CA based Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. On January 16, 2023, Allakos Inc. issued a press release "announc[ing] a restructuring to reduce costs and to focus on AK006 clinical development and additional preclinical programs." The Company stated that it "will halt lirentelimab-related activities across clinical, manufacturing, research and administrative functions" and, "[a]s a result, the Company will reduce its workforce by approximately 50%."

Shares of Allakos Inc. (NASDAQ: ALLK) declined from $3.41 per share on December 18, 2023, to as low as $1.00 per share on January 17, 2024.

Those who purchased shares of Allakos Inc. (NASDAQ: ALLK) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Milestone Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Montreal, Canada based Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. On or about May 9, 2019, Milestone Pharmaceuticals Inc. sold about 5.5 million shares of stock in its initial public stock offering (the "IPO"), at $15.00 a share raising approximately $82,500,000 in new capital.

On December 26, 2023, Milestone Pharmaceuticals Inc announced that it had received a Refuse to File ("RFT") letter from the U.S. Food and Drug Administration ("FDA") for its recently submitted New Drug Application ("NDA") for its lead candidate, Etripamil, a self-administered nasal spray for the treatment of paroxysmal supraventricular tachycardia. The Company advised that, in the RFT, the FDA had "determined that the NDA, submitted in October 2023, was not sufficiently complete to permit substantive review" and "requested clarification about the time of data recorded for adverse events in Phase 3 clinical trials".

Shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) declined from $1.33 per share on January 22, 2024.

Those who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of B. Riley Financial, Inc. (NASDAQ: RILY) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: RILY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Los Angeles, CA based B. Riley Financial, Inc., through its subsidiaries, provides financial services to corporate, institutional, and high net worth clients in North America, Australia, and Europe.

On January 21, 2024, Bloomberg News released an article entitled "SEC Probes B. Riley Deals With Client Tied to Failed Fund". This article stated in pertinent part that "U.S. authorities are investigating B. Riley Financial's deals with a client who was linked to a securities fraud, and the use of his assets to help the investment bank obtain a loan from Nomura Holdings Inc., according to people familiar with the matter."

Shares of B. Riley Financial, Inc. (NASDAQ: RILY) declined from $60.72 per share in July 2023, to as low as $18.09 per share on January 22, 2024.

The plaintiff claims that between May 10, 2023 and November 9, 2023, the Defendants failed to disclose to investors that Brian Kahn had been credibly implicated in a conspiracy to defraud investors of millions of dollars, that, in spite of this involvement, B. Riley continued to finance the transaction enabling Kahn and others to take FRG private through complex arrangements, that the foregoing was reasonably likely to draw regulatory scrutiny to B. Riley, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of B. Riley Financial, Inc. (NASDAQ: RILY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Ramaco Resources, Inc. (NASDAQ: METC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Ramaco Resources, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Lexington, KY based Ramaco Resources, Inc. operates, develops, and sells metallurgical coal. Its development portfolio includes the Elk Creek project located in southern West Virginia; the Berwind property situated on the border of West Virginia and Virginia; the Knox Creek property is located in Virginia; and the RAM Mine property situated in southwestern Pennsylvania. Ramaco Resources, Inc. reported that its annual Total Revenue increased from $283.39 million in 2021 to $565.68 million in 2022, and that its Net Income rose from $39.75 million in 2021 to $116.04 million in 2022.

On December 11, 2023, Wolfpack Research published a report on Ramaco Resources, Inc. entitled "METC: Pumping and Dumping Nearly Worthless Dirt" (the "Wolfpack Report"). Noting that the Company's stock price "recently soared following a Wall Street Journal article that hyped its Brook Mine as a potential source of up to $37 billion in rare earth elements", the Wolfpack Report that "[t]here is no way to profitably mine them" and estimated that the Company "would lose ~$88 billion if they were ever able to extract, process and sell $37 billion of REEs from the Brook Mine." The Wolfpack Report asserted that Ramaco "has likely performed" extractability tests and "is sitting on disappointing results."

Further, the Wolfpack Report noted that "Yorktown Partners, a PE fund that specializes in energy and mining and knows Brook Mine and the management team better than anyone, has sold ~12% of its holdings since November" and that "[o]verall, insiders have dumped $96.3 million in stock since the start of November."

Those who purchased shares of Ramaco Resources, Inc. (NASDAQ: METC) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

A lawsuit was filed on behalf of investors in BioVie Inc. (NASDAQ: BIVI) shares over alleged securities laws violations.

An investor, who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART), filed a lawsuit over alleged violations of Federal Securities Laws by Instacart (Maplebear Inc.).

Investors who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: CART investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based Instacart (Maplebear Inc.) (NASDAQ: CART) doing business as Instacart, provides online grocery shopping services to households in North America.

On August 25, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") in connection with the initial public offering ("IPO"),which, after several amendments, was declared effective by the SEC on September 18, 2023 (the "Registration Statement").

On or around September 19, 2023, Instacart (Maplebear Inc.) conducted its initial public offering ("IPO"), selling 22 million shares of stock priced at $30.00 per share.

On September 20, 2023, Instacart (Maplebear Inc.) (NASDAQ: CART) filed a prospectus on Form 424B4 with the SEC in connection with the IPO, which incorporated and formed part of the Registration Statement (the "Prospectus" and, collectively with the Registration Statement, the "Offering Documents").

Then on September 22, 2023, Reuters published an article noting, among other things, that Instacart's (Maplebear Inc's) (NASDAQ: CART) stock price was falling after "lukewarm analyst reports" indicated that the Company would struggle from heavy competition. For example, the article noted that "BTIG analyst Jake Fuller gave Instacart a 'neutral' rating and warned that the company faces heavy competition from DoorDash (DASH.N) and Uber Technologies (UBER.N) in the slowly expanding market of grocery delivery."

Then, on October 2, 2023, investment research firm Gordon Haskett initiated coverage of Instacart with a "hold" rating, stating that it "ha[s] doubts that online grocery delivery adoption will continue to materially increase at a time when consumers are becoming increasingly cautious about spending", while similarly citing the competitive environment in the online grocery shopping and delivery market as a headwind to the Company's business.

Shares of Instacart (Maplebear Inc.) (NASDAQ: CART) declined to $22.13 per share on January 05, 2024.

The plaintiff alleges on behalf of purchasers of Instacart (Maplebear Inc.) (NASDAQ: CART) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Offering Documents that were filed in connection with the company's IPO were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation.

In addition, the complaint alleges that, September 19, 2023 and October 1, 2023, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating, that Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market, that accordingly, Defendants overstated the Company's post-IPO growth, business, and financial prospects, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Instacart (Maplebear Inc.) (NASDAQ: CART) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Endeavour Mining plc (OTC: EDVMF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Endeavour Mining plc (OTC: EDVMF regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Endeavour Mining plc, together with its subsidiaries, operates as a gold mining company in West Africa.

On January 4, 2024 Endeavour Mining announced the termination of its President and CEO Sebastien de Montessus for serious misconduct. The termination followed an investigation by the Board into an irregular payment of $5.9 million issued by Montessus related to an asset disposal undertaken by the Company.

Shares of Endeavour Mining plc (OTC: EDVMF) declined from $24.35 per share on December 04, 2023, to as low as $16.60 per share on February 05, 2024.

Those who purchased shares of Endeavour Mining plc (OTC: EDVMF) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Evolution AB (publ) (OTC: EVVTY) between February 14, 2019 and October 25, 2023, have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. OTC: EVVTY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sweden based Evolution AB (publ) engages in the development, production, marketing, and licensing of live game shows, casinos, and slots solutions to gaming operators in Armenia, Belgium, Canada, Georgia, Latvia, Lithuania, Malta, Romania, Spain, and the United States.

On October 26, 2023, Evolution AB released its third quarter 2023 Report and held an analyst call in relation thereto.

The plaintiff alleges that in the third quarter 2023 Report and on the October 26, 2023 Analyst Call, Defendants revealed a material fact that had been omitted from Evolution's prior disclosure. The plaintiff claims that the Evolution AB omitted that it was facing delays in opening new studios, a factor materially adverse to Evolution's revenues and that the third quarter 2023 Report revealed that Defendants' July 21, 2023 Statements as to RNG Growth and July 21, 2023 Statement as to North American Growth were misleading, because the third quarter 2023 Report contained financial data revealing that, compared to the preceding quarters' revenues, in the third quarter 2023, Evolution's revenue from each of the RNG and the North American segment of its business did not grow.

Shares of Evolution AB (publ) (OTC: EVVTY) declined from $201.76 per share on May 03, 2021, to as $86.26 per share on October 26, 2023.

The plaintiff claims that between February 14, 2019 and October 25, 2023, the defendants made materially false and/or misleading statements regarding Evolution's and Evolution's customers' compliance with governing laws; the effect of non-compliance on Evolution's revenue; and Evolution's predicted growth and growth strategies. From January 24, 2022 to October 26, 2023, a number of disclosures revealed the truth of Evolution's compliance, revenue, and growth, and brought to light the falsities behind Defendants statements, and that as a result, Evolution AB saw a significant change in the value of its share prices, including its American Depository Shares ("ADSs").

Those who purchased shares of Evolution AB (publ) (OTC: EVVTY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Equity LifeStyle Properties, Inc. (NYSE: ELS regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 22, 2024, Equity LifeStyle Properties, Inc. disclosed in a filing with the U.S. Securities and Exchange Commission that a prior error in the Company's previously filed financial statements determined to be immaterial was in fact, material. The error, which related to the classification of class outflows from the purchase of manufactured homes, led Equity to advise investors that its annual report for 2022 and first quarter report for 2023 should no longer be relied upon.

Those who purchased shares of Equity LifeStyle Properties, Inc. (NYSE: ELS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."

Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.

Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by PTC Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

South Plainfield, NJ based PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. PTC Therapeutics, Inc. reported that its annual Total Revenue rose from $538.59 million in 2021 to $698.8 million in 2022, and that its Net Loss increased from $523.9 million in 2021 to $551.89 million in 2022.

On September 15, 2023, PTC Therapeutics, Inc. issued a press release "announc[ing] . . . that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). The negative opinion also applies to the renewal of the existing conditional authorization."

Then on January 25, 2024, CHMP for a second time issued a negative opinion on Translarna. The negative opinion issued by the Committee will result in the withdrawal of the therapy in Europe.

Those who purchased shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Christopher Clausen

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NYSE: ADM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Chicago, IL based Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities, products, and ingredients in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally. On January 22, 2024, Archer-Daniels-Midland Company placed CFO Vikram Luthar on administrative leave in response to an investigation into accounting practices in its nutrition segment. Archer-Daniels-Midland Company said it will delay publishing its Q4 and FY 2023 results and has withdrawn all forward guidance on the nutrition segment.

Shares of Archer-Daniels-Midland Company (NYSE: ADM) declined from over $87 per share on August 2023 to as low as $50.72 per share on January 25, 2024.

The plaintiff claims that between April 30, 2020 and January 22, 2024, the Defendants made false and/or misleading statements, as well as failed to disclose material facts, about the performance and prospects of Archer-Daniels-Midland Company's Nutrition segment and its accounting practices, and that the Defendants made positive statements about the Nutrition segment as a future profit-driver for the Company, with the ability to capitalize on healthier eating trends and rising consumer demand for natural ingredients and flavoring. Defendants also created the impression that the Nutrition segment's growth would provide more diversification and earnings stability for Archer-Daniels-Midland Company.

The plaintiff claims that unbeknownst to investors, however, the Nutrition segment's ostensibly impressive growth was inaccurate and subject to improper accounting practices, and Defendants also downplayed the segment's eventual decline in 2023, that as Archer-Daniels-Midland Company was aggressively acquiring companies to expand its capabilities in Nutrition, investors were under the impression that the segment was growing rapidly, that as alleged, Defendants' accounting practices for the segment misrepresented its true financial results and prospects, including its operating profits ("OP"), that between April 30, 2020 and January 22, 2024, the defendants were incentivized to create the appearance of a diversified business by inflating the performance of the Nutrition segment, and the Individual Defendants were further incentivized by stock awards that were directly tied to the performance of the Nutrition segment from 2020 to 2022, and that as a result, Archer-Daniels-Midland Company's business and prospects were much worse than represented by Defendants, causing the price of Archer-Daniels-Midland Company common stock to trade at artificially inflated levels between April 30, 2020 and January 22, 2024.

Those who purchased shares of Archer-Daniels-Midland Company (NYSE: ADM) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of United States Steel Corporation (NYSE: X), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by United States Steel Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Pittsburgh, PA based United States Steel Corporation produces and sells flat-rolled and tubular steel products primarily in North America and Europe.

United States Steel Corporation reported that its annual Total Revenue rose from over $20.27 billion in 2021 to over $21.06 billion in 2022, and that its Net Income declined from over $4.17 billion in 2021 to over $2.52 billion in 2022.

Shares of United States Steel Corporation (NYSE: X) closed on February 07, 2024, at $46.07 per share.

Those who purchased shares of United States Steel Corporation (NYSE: X) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Allakos Inc. (NASDAQ: ALLK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Allakos Inc. (NASDAQ: ALLK) concerning whether certain statements by Allakos Inc. (regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

San Carlos, CA based Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. On January 16, 2023, Allakos Inc. issued a press release "announc[ing] a restructuring to reduce costs and to focus on AK006 clinical development and additional preclinical programs." The Company stated that it "will halt lirentelimab-related activities across clinical, manufacturing, research and administrative functions" and, "[a]s a result, the Company will reduce its workforce by approximately 50%."

Shares of Allakos Inc. (NASDAQ: ALLK) declined from $3.41 per share on December 18, 2023, to as low as $1.00 per share on January 17, 2024.

Those who purchased shares of Allakos Inc. (NASDAQ: ALLK) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Milestone Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Montreal, Canada based Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications. On or about May 9, 2019, Milestone Pharmaceuticals Inc. sold about 5.5 million shares of stock in its initial public stock offering (the "IPO"), at $15.00 a share raising approximately $82,500,000 in new capital.

On December 26, 2023, Milestone Pharmaceuticals Inc announced that it had received a Refuse to File ("RFT") letter from the U.S. Food and Drug Administration ("FDA") for its recently submitted New Drug Application ("NDA") for its lead candidate, Etripamil, a self-administered nasal spray for the treatment of paroxysmal supraventricular tachycardia. The Company advised that, in the RFT, the FDA had "determined that the NDA, submitted in October 2023, was not sufficiently complete to permit substantive review" and "requested clarification about the time of data recorded for adverse events in Phase 3 clinical trials".

Shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) declined from $1.33 per share on January 22, 2024.

Those who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of B. Riley Financial, Inc. (NASDAQ: RILY) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NASDAQ: RILY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Los Angeles, CA based B. Riley Financial, Inc., through its subsidiaries, provides financial services to corporate, institutional, and high net worth clients in North America, Australia, and Europe.

On January 21, 2024, Bloomberg News released an article entitled "SEC Probes B. Riley Deals With Client Tied to Failed Fund". This article stated in pertinent part that "U.S. authorities are investigating B. Riley Financial's deals with a client who was linked to a securities fraud, and the use of his assets to help the investment bank obtain a loan from Nomura Holdings Inc., according to people familiar with the matter."

Shares of B. Riley Financial, Inc. (NASDAQ: RILY) declined from $60.72 per share in July 2023, to as low as $18.09 per share on January 22, 2024.

The plaintiff claims that between May 10, 2023 and November 9, 2023, the Defendants failed to disclose to investors that Brian Kahn had been credibly implicated in a conspiracy to defraud investors of millions of dollars, that, in spite of this involvement, B. Riley continued to finance the transaction enabling Kahn and others to take FRG private through complex arrangements, that the foregoing was reasonably likely to draw regulatory scrutiny to B. Riley, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of B. Riley Financial, Inc. (NASDAQ: RILY) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Ramaco Resources, Inc. (NASDAQ: METC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Ramaco Resources, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Lexington, KY based Ramaco Resources, Inc. operates, develops, and sells metallurgical coal. Its development portfolio includes the Elk Creek project located in southern West Virginia; the Berwind property situated on the border of West Virginia and Virginia; the Knox Creek property is located in Virginia; and the RAM Mine property situated in southwestern Pennsylvania. Ramaco Resources, Inc. reported that its annual Total Revenue increased from $283.39 million in 2021 to $565.68 million in 2022, and that its Net Income rose from $39.75 million in 2021 to $116.04 million in 2022.

On December 11, 2023, Wolfpack Research published a report on Ramaco Resources, Inc. entitled "METC: Pumping and Dumping Nearly Worthless Dirt" (the "Wolfpack Report"). Noting that the Company's stock price "recently soared following a Wall Street Journal article that hyped its Brook Mine as a potential source of up to $37 billion in rare earth elements", the Wolfpack Report that "[t]here is no way to profitably mine them" and estimated that the Company "would lose ~$88 billion if they were ever able to extract, process and sell $37 billion of REEs from the Brook Mine." The Wolfpack Report asserted that Ramaco "has likely performed" extractability tests and "is sitting on disappointing results."

Further, the Wolfpack Report noted that "Yorktown Partners, a PE fund that specializes in energy and mining and knows Brook Mine and the management team better than anyone, has sold ~12% of its holdings since November" and that "[o]verall, insiders have dumped $96.3 million in stock since the start of November."

Those who purchased shares of Ramaco Resources, Inc. (NASDAQ: METC) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Investors who purchased shares of Anywhere Real Estate Inc. (NYSE: HOUS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Anywhere Real Estate Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Madison, NJ based Anywhere Real Estate Inc., through its subsidiaries, provides residential real estate services in the United States and internationally. On October 6, 2023, Anywhere Real Estate Inc. announced a settlement agreement for the Burnett and Moehrl antitrust class action litigation. The proposed settlement, which still requires court approval, would oblige Anywhere to provide monetary relief of $83.5 million, alongside injunctive relief. This settlement amount aligns with the company's financial planning.

Shares of Anywhere Real Estate Inc. (NYSE: HOUS) declined from $8.48 per share on August 03, 2023, to as low as $4.14 per share during October 23, 2023.

Those who purchased shares of Anywhere Real Estate Inc. (NYSE: HOUS) have certain options and should contact the Shareholders Foundation.

Contact:

Shareholders Foundation, Inc.

Michael Daniels

3111 Camino Del Rio North - Suite 423

92108 San Diego

Phone: +1-(858)-779-1554

Fax: +1-(858)-605-5739

mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Former employees of TuSimple Holdings Inc. should contact the Shareholders Foundation in connection with a lawsuit that are pending against TuSimple Holdings Inc.

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- Former employees of TuSimple Holdings Inc. should contact the Shareholders Foundation in connection with a lawsuit that is pending against TuSimple Holdings Inc. over alleged securities laws violations.

If you worked for TuSimple Holdings Inc. (NASDAQ: TSP), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On August 31, 2022, a lawsuit was filed against TuSimple Holdings Inc. (NASDAQ: TSP) over alleged Securities Laws Violations. The plaintiff claimed that the defendants made materially false or misleading statements and/or failed to disclose, inter alia, that TuSimple Holdings' commitment to safety was significantly overstated and Defendants concealed fundamental problems with the Company's technology, that TuSimple Holdings was rushing the testing of its autonomous driving technology in order to deliver driverless trucks to the market ahead of its more safety-conscious competitors, that TuSimple Holdings there was a corporate culture within TuSimple that suppressed or ignored safety concerns in favor of unrealistically ambitious testing and delivery schedules, that the aforementioned conduct made accidents involving the Company's autonomous driving technology more likely, that the aforementioned conduct invited enhanced regulatory scrutiny and investigatory action toward the Company, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

On Jan. 12, 204, San Diego based TuSimple Holdings Inc. announced it would start selling off assets, including their trucks, research and development equipment, and even office supplies between January 23 and February 8, 2024.

Recently a temporarily restraining order was granted by Federal Judge Roger Benitez of the U.S. District Court for the Southern District of California. The Judge granted a temporary restraining order to prevent TuSimple Holdings Inc. from selling off its assets and moving overseas, amid claims it's trying to escape charges of misappropriating trade and national security secrets.

Those worked for TuSimple Holdings Inc. (NASDAQ: TSP), you have certain options and you should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Several lawsuits have been filed on behalf of consumers with an account at 23andMe Holding Co. (NASDAQ: ME) and affected 23andMe Holding Co account holders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- The Shareholders Foundation announced that several lawsuits were filed by consumers with an account at 23andMe Holding Co. (NASDAQ: ME) in connection with the massive data breach in the end of 2023.

If you have or had an account with 23andMe Holding Co. (NASDAQ: ME), you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

San Francisco, CA based 23andMe Holding Co. operates as a consumer genetics testing company. In October 2023 23andMe Holding Co. disclosed that hackers had obtained some users' data, but stopped short of calling the incident a data breach. It was later revealed that the breach reportedly affected 6.9 million individuals in total.

The attack targeted the personal information of 23andMe Holding Co. users compromising individual's personal information such as full name, birth year, email address, and sex, along with information on genetic ancestry, potential relatives, and geolocation.

It was later revealed that hackers started breaking into customers' accounts in April 2023 and continued through most of September and that hackers seem to have targeted customers with Chinese and Ashkenazi Jewish heritage.

Those who have or had an account with 23andMe Holding Co. (NASDAQ: ME), you have certain options and you should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

A Deadline is coming up on February 5, 2024 in the lawsuit for certain investors in Blue Ridge Bankshares, Inc. (NYSE: BRBS).

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- A deadline is coming up on February 5, 2024 in the lawsuit filed for certain investors of Blue Ridge Bankshares, Inc. (NYSE: BRBS).

Investors who purchased shares of Blue Ridge Bankshares, Inc. (NYSE: BRBS) have certain options and there are strict and short deadlines running. Deadline: February 5, 2024. NYSE: BRBS stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of Blue Ridge Bankshares, Inc. (NYSE: BRBS) common shares between March 10, 2023 and October 31, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 10, 2023 and October 31, 2023, the defendants made materially false and/or misleading statements and/or failed to disclose that Blue Ridge Bankshares, Inc.'s financial statements from March 10, 2023 to the present included certain errors, that as a result, Blue Ridge Bankshares would need to restate its previously filed financial statements from March 10, 2023 to October 31, 2023, and that as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

Those who purchased shares of Blue Ridge Bankshares, Inc. (NYSE: BRBS) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in Amtech Systems, Inc. (NASDAQ: ASYS) shares over potential securities laws violations by Amtech Systems, Inc. was announced.

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- Amtech Systems, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Amtech Systems, Inc. (NASDAQ: ASYS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Amtech Systems, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Temple, AZ based Amtech Systems, Inc. manufactures and sells capital equipment and related consumables for use in fabricating silicon carbide (SiC), silicon power devices, analog and discrete devices, electronic assemblies, and light-emitting diodes (LEDs) worldwide. Amtech Systems, Inc. reported that its Total Revenue rose from $106.29 million for the 12 months period that ended on September 30, 2022, to $113.31 million for the 12 months period that ended on September 30, 2023, and that its Net Income of $17.36 million for the 12 months period that ended on September 30, 2022, turned to a Net Loss of $12.58 million for the 12 months period that ended on September 30, 2023.

On December 13, 2023, Amtech Systems, Inc. announced that it anticipated taking an impairment charge in its Materials and Substrate segment in part due to a "prolonged downturn . . . in the semiconductor industry and delays in the adoption of next-gen polishing tools."

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) declined from $11.98 per share in July 2023, to as low as $3.59 per share on December 19, 2023.

Those who purchased shares of Amtech Systems, Inc. (NASDAQ: ASYS) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

A Deadline is coming up on February 5, 2024 in the lawsuit for certain investors in The Estée Lauder Companies Inc. (NYSE: EL).

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- The Shareholders Foundation announced that a deadline is coming up on February 5, 2024 in the lawsuit filed for certain investors of The Estee Lauder Companies Inc. (NYSE: EL).

Investors who purchased shares of The Estee Lauder Companies Inc. (NYSE: EL) have certain options and there are strict and short deadlines running. Deadline: February 5, 2024. The Estee Lauder Companies Inc. (NYSE: EL) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges on behalf of purchasers of The Estee Lauder Companies Inc. (NYSE: EL) common shares between August 18, 2022 and May 2, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 18, 2022 and May 2, 2023, the defendants misled investors with unrealistic and materially false statements about market demand Estee's products and its inventory levels and that these statements concealed the truth about Estee's weakness in the market until, on May 3, 2023, Estee announced weaker sales and profit for the year than estimated and accordingly cut its fiscal year outlook for a third consecutive time.

Those who purchased shares of The Estee Lauder Companies Inc. (NYSE: EL) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

A lawsuit was filed on behalf of investors in GrafTech International Ltd. (NYSE: EAF) shares over alleged securities laws violations.

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- An investor, who purchased shares of GrafTech International Ltd. (NYSE: EAF), filed a lawsuit against GrafTech International Ltd. over alleged violations of Federal Securities Laws.

Investors who purchased shares of GrafTech International Ltd. (NYSE: EAF) have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2024. NYSE: EAF investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Brooklyn Heights, OH based GrafTech International Ltd. research, develops, manufactures, and sells graphite and carbon-based solutions worldwide. On September 19, 2022, GrafTech International Ltd. announced that Mexican authorities suspended operations at its facilities in Monterrey, Mexico, and determined that its operating license within the country was no longer in effect. The suspension related "procedural errors related to certain operating licenses and permits."

On November 4, 2022, GrafTech International Ltd. held an earnings conference call during which management addressed the Monterrey closing. Specifically, management stated that "unless Monterrey reopens, our business performance will be significantly impacted for the first two quarters of 2023 with a reduction in sales volume of 50% or more before recovering the in the back half of the year."

Then on November 18, 2022, GrafTech International Ltd. announced the conditional lifting of the temporary suspension notice related to the Company's operations. The announcement explained that the Company "will provide an update on estimated impact of the suspension on its 2023 outlook when it reports its fourth quarter 2022 results."

On February 3, 2023, GrafTech International Ltd. issued its first quarter results and hosted an earnings call. Therein, management clarified that "we estimate our sales volume for the first six months of this year will be approximately half of the level we reported in 2022."

Shares of GrafTech International Ltd. (NYSE: EAF) declined from $6.74 per share on February 02, 2023 to as low as $2.20 per share on November 10, 2023.

The plaintiff claims that between February 8, 2019 and August 3, 2023,, the defendants made false and/or misleading statements and/or failed to disclose that GrafTech's manufacturing operations in Monterrey, Mexico had for decades chronically contaminated neighboring communities with harmful carcinogenic gasses and particulate matter, that GrafTech had signed agreements with local authorities committing itself to improving the environmental performance of its Monterrey facility, but repeatedly failed to honor these commitments, that GrafTech had been repeatedly warned over an approximately 30-year period regarding its wanton disregard for the environment and health and well-being of people near its operations in Monterrey, Mexico, that GrafTech's operations in Monterrey, Mexico were not in compliance with applicable environmental laws and regulations, that GrafTech had failed to adequately remediate the environmental problems caused by the Monterrey facility following the 2019 administrative proceeding conducted by the Department of Sustainable Development of the State of Nuevo Leon, that the government of Apodaca had sought intervention from the State of Nuevo Leon authorities to curtail and prevent the adverse environmental impacts and noncompliance with environmental laws and regulations caused by the Monterrey facility, that GrafTech's purported cost leadership was achieved in substantial part by failing to implement appropriate and effective environmental safeguards at its manufacturing facility in Monterrey, Mexico, that GrafTech's capital expenditures and/or related operational projects were woefully insufficient to adequately address the harm that GrafTech's operations in Monterrey, Mexico had inflicted on the environment and people within the neighboring communities, that as a result of the above, GrafTech was acutely exposed to undisclosed material risks that GrafTech's manufacturing operations in Monterrey, Mexico would be severely disrupted by government action or enforcement; and that as a result of the above, GrafTech was acutely exposed to undisclosed material risks that its supplies of pin stock and graphite electrodes would be withdrawn and/or materially diminished, thereby materially harming GrafTech's business, operations, reputation, and financial results.

Those who purchased shares of GrafTech International Ltd. (NYSE: EAF) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in MiMedx Group, Inc. (NASDAQ: MDXG) shares over potential securities laws violations by MiMedx Group, Inc. was announced.

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- An investigation was announced concerning potential securities laws violations by MiMedx Group, Inc. in connection with certain financial statements.

Investors who purchased shares of MiMedx Group, Inc. (NASDAQ: MDXG), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by MiMedx Group, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Marietta, GA based MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. On December 29, 2023, MiMedx Group, Inc. announced that "[f]ollowing a routine inspection earlier in the year, the United States Food and Drug Administration ("FDA") took the position that one of the Company's recently-launched placental-derived tissue products – AXIOFILL – does not meet the requirements as a Section 361 product and is therefore subject to enforcement as a Section 351 product. Specifically, FDA asserts that the production of AXIOFILL involves more than "minimal manipulation." The Company does not agree with FDA's position and has been actively engaged with the agency through its "Request For Designation" ("RFD") process. However, on December 21, 2023, MIMEDX received a Warning Letter from FDA reiterating the agency's position on AXIOFILL." Shares of MiMedx Group, Inc. (NASDAQ: MDXG) declined from $9.27 per share on December 20, 2023, to $7.61 per share on January 04, 2023.

Those who purchased shares of MiMedx Group, Inc. (NASDAQ: MDXG) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation on behalf of investors in Amplitude, Inc. (NASDAQ: AMPL) shares over potential wrongdoing at Amplitude, Inc. was announced.

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- Certain directors of Amplitude, Inc. are under investigation over potential breaches of fiduciary duties.

Investors who purchased shares of Amplitude, Inc. (NASDAQ: AMPL) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Amplitude, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

San Francisco, CA based Amplitude, Inc. provides a digital analytics platform to analyze customer behavior within digital products in the United States and internationally. Amplitude, Inc. reported that its annual Total Revenue rose from $167.26 million in 2021 to $238.06 million in 2022, and that its Net Loss increased from $74.98 million in 2021 to $91.9 million in 2022.

Shares of Amplitude, Inc. (NASDAQ: AMPL) declined from $16.95 per share on February 15, 2023, to as low as $8.50 per share on May 16, 2023.

Those who purchased shares of Amplitude, Inc. (NASDAQ: AMPL) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation on behalf of current long term investors in Generac Holdings Inc (NYSE: GNRC) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- Certain directors of Generac Holdings Inc are under investigation concerning potential breaches of fiduciary duties.

Investors who are current long term investors in Generac Holdings Inc (NYSE: GNRC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NYSE: GNRC stocks follows a lawsuit filed against Generac Holdings Inc over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: GNRC stocks, concerns whether certain Generac Holdings Inc directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that, the defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated the price of Generac Holdings Inc (NYSE: GNRC) stock and operated as a fraud or deceit purchasers of Generac Holdings Inc (NYSE: GNRC) stock between May 3, 2023 and August 3, 2023 by failing to disclose and misrepresenting adverse facts detailed in the Complaint and that when Defendants' alleged misrepresentations were disclosed and became apparent to the market on August 2, 2023, the price of Generac Holdings Inc (N YSE: GNRC) stock fell precipitously.

Those who purchased shares of Generac Holdings Inc (NYSE: GNRC) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation for investors in Gildan Activewear Inc. (NYSE: GIL) shares over potential securities laws violations by Gildan Activewear Inc. was announced.

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- Gildan Activewear Inc. is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Gildan Activewear Inc. (NYSE: GIL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Gildan Activewear Inc. (NYSE: GIL) concerning whether a series of statements by Gildan Activewear Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Gildan Activewear Inc. manufactures and sells various apparel products in the United States, North America, Europe, Asia-Pacific, and Latin America. Gildan Activewear Inc. reported that its annual Total Revenue rose from over $2.92 billion in 2021 to over $3.24 billion in 2022 and that its Net Income declined from $607.18 million in 2021 to $541.54 million in 2022.

Shares of Gildan Activewear Inc. (NYSE: GIL) declined from $37.33 per share on December 08, 2023, to as low as $30.68 per share on January 16, 2024.

Those who purchased shares of Gildan Activewear Inc. (NYSE: GIL) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

An investigation on behalf of current long term investors in Comerica Incorporated (NYSE: CMA) shares over possible breaches of fiduciary duty by certain officers and directors was announced.

San Diego, CA -- (SBWIRE) -- 02/05/2024 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Comerica Incorporated.

Investors who are current long term investors in Comerica Incorporated (NYSE: CMA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for investors in NYSE: CMA stocks follows a lawsuit filed against Comerica Incorporated over alleged securities laws violations. The investigation on behalf of current long term investors in NYSE: CMA stocks, concerns whether certain Comerica Incorporated directors are liable in connection with the allegations made in that lawsuit.

The plaintiff alleges that, the defendants made false and/or misleading statements and/or failed to disclose, among other things, that Comerica failed to provide meaningful oversight over the vendors to whom it contracted out day-to-day operations of the Direct Express program, a system through which it is contracted to provide federal benefits to millions of Americans without bank accounts, that as a result of violations in the day-to-day operations of Direct Express, including handling fraud disputes and allowing sensitive data to be handled out of a vendor's office in Pakistan, Comerica was not in compliance with the Federal Contract, and knew it was not in compliance, that Comerica knew and failed to disclose that it was in potential violation of Regulation E due to inadequate fraud prevention in the Direct Express program and responses to instanced of fraud, and that as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of Comerica Incorporated (NYSE: CMA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm